Introduction: The prevalence of drug therapy problems in patients with epilepsy has been reported to be as high as 70–90%. Moreover, elderly patients with epilepsy are highly vulnerable to ...
As shown in Figure 2 and 3, the pooled SMDs for alogliptin 12.5 mg treated vs controls, and alogliptin 25 mg treated vs controls demonstrated a significant reduction in HbA1c in patients treated ...
Morgera, Elisa 2015. Fair and Equitable Benefit-Sharing at the Cross-Roads of the Human Right to Science and International Biodiversity Law. Laws, Vol. 4, Issue. 4, p. 803. Fusi, Federica Welch, Eric ...